Efficacy of EZH2 Inhibitory Drugs in Human Papillomavirus-Positive and Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinomas

Clinical Epigenetics - Germany
doi 10.1186/s13148-017-0390-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search